Proto Labs, Inc. — Q3 2015 Form 10-Q
Business context and reporting period. The unaudited quarter ended September 30, 2015; comparisons are with Q3 2014. Proto Labs provides on-demand custom parts through injection molding (Protomold), CNC machining (Firstcut), and additive manufacturing (Fineline). FineLine, acquired in April 2014, is included in comparative results from its acquisition date.
Financial performance
| Metric | Q3 2015 | Q3 2014 | Nine months 2015 | Nine months 2014 |
|---|---|---|---|---|
| Revenue | $67.8M | $54.6M | $190.3M | $153.5M |
| Gross profit / margin | $40.3M / 59.4% | $33.1M / 60.6% | $113.1M / 59.4% | $94.8M / 61.7% |
| Operating income / margin | $17.4M / 25.7% | $15.4M / 28.3% | $50.6M / 26.6% | $45.9M / 29.9% |
| Net income | $12.4M | $10.4M | $34.5M | $31.4M |
| Diluted EPS | $0.47 | $0.40 | $1.31 | $1.20 |
Q3 revenue rose 24.3% year over year; net income increased 19.2%. For the first nine months, revenue grew 24.0%, while net income rose 9.8%. Lower gross and operating margins reflected manufacturing capacity expansion, foreign-exchange effects, and operating expenses growing faster than revenue in several categories.
Revenue mix and demand. Q3 Protomold revenue was $42.0M (+17.7%), Firstcut $19.8M (+27.6%), and Fineline $6.0M (+79.2%). The company served about 12,500 unique product developers and engineers in Q3, up 24%; average revenue per customer was described as consistent. U.S. revenue grew 23.0% and international revenue 28.2%. Currency movements reduced Q3 international revenue by $2.1M. For the nine months, customer count rose 29%, while average revenue per customer declined 4.0%; international revenue was reduced by an estimated $6.1M by currency effects.
Cash, liquidity, and balance sheet
- At September 30, cash and cash equivalents were $64.1M and marketable securities totaled $85.9M; total current assets were $142.5M against current liabilities of $24.5M.
- Total assets were $341.9M and shareholders’ equity was $314.2M. Debt obligations were $39,000 current and no long-term debt was reported.
- Nine-month operating cash flow was $41.3M, versus $40.0M in 2014. Investing cash outflow was $29.0M, including $27.3M of property and equipment purchases; financing inflow was $8.9M. Cash increased $20.8M from year-end 2014.
- Management says operations and capital expenditures have historically been financed primarily through operating cash flow, with some lease financing. No off-balance-sheet arrangements were reported.
Changes, outlook, and risks
- Cost of revenue increased 28.0% in Q3, faster than revenue growth, due mainly to materials and production costs and higher direct-labor headcount. Gross margin fell 1.2 percentage points year over year.
- Q3 marketing and sales expense rose 36.4%, and general and administrative expense rose 41.9%; the latter included $0.6M of Alphaform-related costs. Management expects continued investment in personnel, marketing, technology, and manufacturing capacity, with operating expenses expected to increase. It expects cost of revenue to rise in dollars but remain relatively constant as a percentage of revenue. No specific revenue or earnings guidance is provided.
- In October 2015, after quarter-end, the company acquired certain assets and shares of Alphaform AG for $5.5M. The filing does not provide post-acquisition operating results.
- Foreign-exchange exposure is unhedged. Management says a hypothetical 10% adverse currency move could materially affect operating results, though it would generally not materially affect financial position. The company recorded Q3 foreign-currency income of $0.4M and a nine-month loss of $0.4M.
- Unrecognized tax-benefit liabilities were $1.7M at quarter-end; the company expected changes in uncertain tax positions over the next year, not expected to be material. Management reported no material litigation exposure, no material change in previously disclosed risk factors, and effective disclosure controls.
- The company prospectively changed the estimated useful lives of primary production equipment during Q3; management said the change was not material. Adoption of the new revenue-recognition standard was deferred to periods beginning after December 15, 2017; the company was evaluating adoption and did not expect a material impact.
Important facts for investors to verify
- Whether manufacturing-capacity investments and labor costs stabilize and margins recover as revenue expands.
- Whether customer growth converts to sustained revenue growth, particularly given the nine-month decline in average revenue per customer.
- Alphaform’s integration, contribution, and any additional acquisition-related costs following the $5.5M purchase.
- The sensitivity of international revenue and profitability to exchange rates, given the absence of hedging.
- Capital-spending requirements, cash conversion, and the future treatment and impact of stock-based compensation and tax benefits.